CA2167573A1 - Sleeve catheter - Google Patents
Sleeve catheterInfo
- Publication number
- CA2167573A1 CA2167573A1 CA002167573A CA2167573A CA2167573A1 CA 2167573 A1 CA2167573 A1 CA 2167573A1 CA 002167573 A CA002167573 A CA 002167573A CA 2167573 A CA2167573 A CA 2167573A CA 2167573 A1 CA2167573 A1 CA 2167573A1
- Authority
- CA
- Canada
- Prior art keywords
- catheter
- head portion
- balloon
- sleeve
- wall
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 claims abstract description 28
- 210000000056 organ Anatomy 0.000 claims abstract description 4
- 230000008595 infiltration Effects 0.000 claims description 5
- 238000001764 infiltration Methods 0.000 claims description 5
- 238000009736 wetting Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 15
- 238000000034 method Methods 0.000 description 9
- 230000010339 dilation Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 2
- GRYSXUXXBDSYRT-WOUKDFQISA-N (2r,3r,4r,5r)-2-(hydroxymethyl)-4-methoxy-5-[6-(methylamino)purin-9-yl]oxolan-3-ol Chemical compound C1=NC=2C(NC)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1OC GRYSXUXXBDSYRT-WOUKDFQISA-N 0.000 description 1
- 241000370685 Arge Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 102000004726 Connectin Human genes 0.000 description 1
- 108010002947 Connectin Proteins 0.000 description 1
- 102100027371 Cysteine-rich PDZ-binding protein Human genes 0.000 description 1
- 101000726276 Homo sapiens Cysteine-rich PDZ-binding protein Proteins 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 101150050071 proY gene Proteins 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000002226 simultaneous effect Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/0029—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the middle part of the catheter, e.g. slots, flaps, valves, cuffs, apertures, notches, grooves or rapid exchange ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22001—Angioplasty, e.g. PCTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M2025/0036—Multi-lumen catheters with stationary elements with more than four lumina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M2025/004—Multi-lumen catheters with stationary elements characterized by lumina being arranged circumferentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1068—Balloon catheters with special features or adapted for special applications having means for varying the length or diameter of the deployed balloon, this variations could be caused by excess pressure
Abstract
In a sleeve catheter (10) for supplying medicine to the walls of a vessel or tubular organ in which a number of outer lumina (18) extend longitudinally around a central lumen, the outer lumina have radial discharge openings (24) in the area of the head portion (16) of the catheter, which is slidable onto a balloon catheter (11) in order to be disposed at least partially on the balloon of the balloon catheter so as to be expandable thereby into abutment with the inner wall of a vessel to be dilated whereby medicine can be supplied through the discharge openings (24) in the outer lumina under pressure directly to the tissue of the vessel adjacent the outer lumina, thereby applying the medicine solely to the area engaged by the outer surface of the head portion (16).
Description
SLEE~E CATHETER
~KGROUND OF T~F I~F~TIoN
-- The invention relates to a 5t ee~e catheter for the wetting and infiltration o~ a veSsel wall with 2 fluid partic41arlY. medicine, preferably durins ro~tine treatment with a balloon cathete,-.
For the tr~tment of constricted Pas6ages in arteries, ~alloon dilation ~s recogni2ed as an only lit-tle invasl~e ~ut very effective and eleg~nt method.
ExPerie~re however shows that this treatment method h2; a high recurrence rate in the order of ~bout 30~ of the treated patient 5 , tha t i S , W i thin a Peri G d of seve ~2 1 months, for examP~e, between 3 ~nd 6 months, Passage c~r,-5triction will reoccur. It has bean shown that this i5 at least partly caused by ce~l growth which is caus~d bY
the balloon dilation, that is, bY exp~nsion and rupture ~f the tissue. It i5 theref2~e desirable to pro~ide for the vessel area which is subiected to such balloor, dila-tion additional treatment which counteracts such tissue growth.
Various methods for growth-inhi~iting treatment are kno~n, p~rticularly, the aPPlication of energy, for example, bY ~eans of a laser or th~ ~oc~lized treat~ent with sPecial medicine. As carrier for the localized treatment with medicine it is known to use wire wall sup-~S ports ~so-c~lled stents) whcse use however is comPlicaie~
and which cannot be remo~ed.
- 2l 6-1573 It has al 50 been ProPosed to use ball~on catheters with perfo~ated b~lloons so that J during the dilation Procedure, medication can be 2dministered for penetration into the tissue. ~o~e~er. this proposa~ was S found to be unsu~table since already at the beginnin~ o~, and durins, balloon exPansion, uncontr~llable amrunts of medicine are lost s~ t hat i t becomes imposs i b 1 P t o ap? 1 y a defined amount of medicine to th~ tissue wal 1 areas to be treated for wetting of th. tissue and infiltrztian into the tissue wall. 0urin inflation of the ballc3n.
that is, before the ~lloon w~ll abuts the ~essel wall, a - subst~ntial amrunt of the med~cine is released and this prenlaturel y rel ~s~d amount Or medIcine d~es n~t re~ch the vessel l~yers to be treated snd, conse~uentlY, an undesirably hi~h dosage is required if the Particulsr vessel area ta be treated is to be expGse~ to a suffi-cient amount sf ~edicine. Another disad~antage is seen in the fact that onlY an i~sufficient amount of pressure c~n ~e generated with a perforated balloon which maY not ~e enough to ~xPand the restricted vessel area.
It is desirable to overcome the disad~ntaces as described ln connection with a perforate4 bal)oon, wherein however the effectiveness and the ele~anc~ of balloon dil~tion shauld be maintained and m~dication
~KGROUND OF T~F I~F~TIoN
-- The invention relates to a 5t ee~e catheter for the wetting and infiltration o~ a veSsel wall with 2 fluid partic41arlY. medicine, preferably durins ro~tine treatment with a balloon cathete,-.
For the tr~tment of constricted Pas6ages in arteries, ~alloon dilation ~s recogni2ed as an only lit-tle invasl~e ~ut very effective and eleg~nt method.
ExPerie~re however shows that this treatment method h2; a high recurrence rate in the order of ~bout 30~ of the treated patient 5 , tha t i S , W i thin a Peri G d of seve ~2 1 months, for examP~e, between 3 ~nd 6 months, Passage c~r,-5triction will reoccur. It has bean shown that this i5 at least partly caused by ce~l growth which is caus~d bY
the balloon dilation, that is, bY exp~nsion and rupture ~f the tissue. It i5 theref2~e desirable to pro~ide for the vessel area which is subiected to such balloor, dila-tion additional treatment which counteracts such tissue growth.
Various methods for growth-inhi~iting treatment are kno~n, p~rticularly, the aPPlication of energy, for example, bY ~eans of a laser or th~ ~oc~lized treat~ent with sPecial medicine. As carrier for the localized treatment with medicine it is known to use wire wall sup-~S ports ~so-c~lled stents) whcse use however is comPlicaie~
and which cannot be remo~ed.
- 2l 6-1573 It has al 50 been ProPosed to use ball~on catheters with perfo~ated b~lloons so that J during the dilation Procedure, medication can be 2dministered for penetration into the tissue. ~o~e~er. this proposa~ was S found to be unsu~table since already at the beginnin~ o~, and durins, balloon exPansion, uncontr~llable amrunts of medicine are lost s~ t hat i t becomes imposs i b 1 P t o ap? 1 y a defined amount of medicine to th~ tissue wal 1 areas to be treated for wetting of th. tissue and infiltrztian into the tissue wall. 0urin inflation of the ballc3n.
that is, before the ~lloon w~ll abuts the ~essel wall, a - subst~ntial amrunt of the med~cine is released and this prenlaturel y rel ~s~d amount Or medIcine d~es n~t re~ch the vessel l~yers to be treated snd, conse~uentlY, an undesirably hi~h dosage is required if the Particulsr vessel area ta be treated is to be expGse~ to a suffi-cient amount sf ~edicine. Another disad~antage is seen in the fact that onlY an i~sufficient amount of pressure c~n ~e generated with a perforated balloon which maY not ~e enough to ~xPand the restricted vessel area.
It is desirable to overcome the disad~ntaces as described ln connection with a perforate4 bal)oon, wherein however the effectiveness and the ele~anc~ of balloon dil~tion shauld be maintained and m~dication
2~ t~atment 4f the tissue and the v~ssel wall should be facilitated durins the same prcoedure without essential additional time inPut. It i 5 therefure the object of the invention to imProve the established balloon c~th~ter procedure such that, on one hand. the high recurrence rate can be reduced by the simultaneou~ administration of med3cinet and, on the other hand, tne medieir,e is admin-istered in the desired dosage and is applied es5entiallY
only to the tissue areas to be treated.
SU~MAR~ OF THF INVFNTION
In a sleeve catheter for 5uppl ying medicine to the walls of a vessel or tubular or~an in which a num~er of outer lumina extend longitudinallY around a c~ntral lumen, the outer lumina have radial discharge o~enings in the area of the head portion of the catheter, which i5 slidable onto a balloon catheter in order ta be dispose~
at least P~rtiallY on the ballo~n of the balloon cathete~
s so as to ~e expandable therebY into abutment with the inner wa1l of a ~essel to be dil~tet wherPby medicine can be supplied through the discha~ge openings in the auter tumina under pressure directty to the tissue cf the ves-sel adjacent the outer lu~ina, thereby ~pplyin~ the medicine solely to the area engaged by the outer surfac~
Gf ~he head portion.
The arrangement according ta the invention h~s the ~d~antag~ that the ~lee~e catheter i5 51 idable onto a ?ortion of the de~lated balloon Or a b~lloon catheter. so ~5 that the low balloon Profile as required for the inser-tion Or the catheter into constricted ~essel area is essentially mainta1ned. Inflation o~ the ballo3n forces the head porticn of the sleeve c~theter into engage~ent with the tissue t~ be treated 50 that, during the dila-tioo procedure the medicine can b~ appl ied, under pres-sure, through the outer l~mina directlY to the tissue to be treated whereby it entens solely this t~sl~e. In this manner all toxic c~mpounds or gene-technologicallY desig-n~ted medicine adaP~ed to inhibit undesirable cell growth 2s in the tr~eated area can be inJected directl y and onl y into the tissue a~ea to be tre.atet.
In a further embodiment accordin~ to the inven-tion the Perforation; are pre~ormed such that they are oPened by application Gf the b~llaon Pressure. They may also be prefarmed in suoh a manner that they are oPened by the applicatiQn of additi~nal pressure to the outer 1umlna.
In order to facil itate the exPansion of the head portion o~ the slee~e catheter, in ~nnther embodi-ment, the head portion is P~o~ided at its outside ~etweenthe dischar~e oPenings with largitudinally extending r~dial notches. ExPansion c~n be fu~ther facilitated by providing longitudinally extenting radial notches al~o in the inner w~ll, bet~een the outer lumina, ~hich i5 dIS-Posed adjacent the inner lumen of the catheter.
In order to administer the medicine as locally as possible. that is, only in the close Pno~imity of the constricted vessel area, or stenosis, it is advan~ageous if the discharge openings are preformed in such a mznner thAt they are oPened sradually with increasing pressure.
beg~nning at the distal end, to~rd the proximal end of IO the head portion. ~epending on the locatiGn where the sleeve catheter i5 to be used in ~onnection wit~ a bal-loon catheter, in vessels or in crgans, it may ~e advan-tageou$ to ~dminister di~ferent am~unts of med~cine for ~etting the tl55ue Qr infiltration into the tissue. It 1~ ls therefore within the scoPe of the presert invention to provide distributed over the circum~erence Or the head portion, 5iX tD twentY outer lumina.
pRIF~ DFSCRLPTI~N ~F THF D~INGS
Th~ advant~ges and features o~ the lnvention are aPParent from the following descriPtion of an embodi-ment d~scribed below with reference to the drawings and def$ne~ in the claims.
Figure 1 shows the head porticn of a 51 eeve catheter disPosed on a ~alloon ~atheter;
Fig. 2 is a cross-sactional view cf the front end o~ the balloon catheter with the h~ad portion of the slee~e catheter disPosed therean Fig. 3 is a c~o~s-sectiona1 view of the inflated ballnon with an exPanded head portion of the 30 51 eeve c~thater, ~ ig. 4 is a cross-sectional view along l ines T~-IV of Fig. 1; and Fig. 5 sho~s the connecting struct~re ~or the operation of the baltoon catheter and the sleeve catheter.
D~$CRIPT~ON OF T~F PRFFRRFD F~ODI~FNT
Figs . 1. ~ and 3 show the detail5 o~ a 51 eeve catheter 1~ dispcsed Gn a bal~oon catheter 11. The sleeve catheter is sliPped onto the bal~oon catheter such that the head Pcrtion 16 extends at least PartiallY oYer the ~allGon 12 which i5 mounted on a flexible guide rod 14 as shown in Fig. 2. In these relative Positions the two catheters are inserted into a vessel or an organ.
~he cuter lumina 18 ter~inate in the head portion cf the 10 51 e~ve catheter and they extend ove~ the full length of the 51 eeve catheter uP to the conneoting structure which is sh~wn in Fig. 5 and explained be~Gw. As shown the outer lumina 18 are arranged in a circle around a central lu~en 20 wherein 6 to 20 4uter lumina maY be pro~ided dePendin~ on the 5ize and the applica~ion area of the sleeve catheter.
It is al S4 p055i~1 e to provide only one or t~o lumina which extend along the sleeve catheter and ~hich ~re divided ~n the head portion inta several outer lumina. The cross-secticn and the arrangement of the lumina are ad~pted to a particular aPp~ication.
In the cross-sectional ~iew of Fig. 4 which is t~ken acr~ss a head porti~n 16 disPoset on a balloon catheter 11. t~ere are ei~ht outer lumin 18 which are - 23 proYided with discharge oPenings 24 leading to the out-side of the head portion. These discharge openings 24 are so designed that theY open only toward the end of balloon pressure aPPlication and then discharge a medicine contained in the outer lumina 1~. It is alsa Possible to preform the discharge ~Penings in 5vch a way that theY open ~nly bY ~PPlication of additional Pressure applied via the connectin~ structure.
In orde~ to facilitate expansion of the head portion 16 it is proY~ded~ at least on the outside, with radial grooves 22 which extent longitudinally between the discharge ~Penings 24 and to a li~ited dePth sPaced from the inner wall of the head Po~tion 50 as to provide for a hin~e structure allowing the radial Sr~oves 22 tc open up and exPand the head portion with on~y sma~l pressure re~uirements. ~n order to ~urther reduce the pressure required for the exPansion of the head portion further radial grooves 23 may ~e provided at the inside of the head portion adjacent the central lumer, 20, the gr~oves 23 extending lon~itudinally between the outer lumin~ 18.
I~ t!~o radial grooves 23 are provided at ~PPosite sides Ot a radial gr~ove ~, three-hinse structures ane form~d which further facilitate exPansion of the head portion.
: With this arran~ement the head portion can be Pressed in sufficiently tight cnntact with the ves~el ~all 5 bY the pressure of, for example, 5 to 8 bar required for full exPansion of the balloon 50 that the medicine, when aPPlied throu~h the oute~ luminc 18 ~nt the disc~arge openin~s 24, will not ~low ~aY but will be applied tn the inner ~all surface in a highly locati~ed fashior, such that it ~ill Penetr~te the wall a~d then infiltrate the inner layers in sufficientlY high concen-trations~
For good distribution ~f the me~icine duringdilation when the head PGrtion is firmlY pressed against the expanded tissue by the pressure built up in ths inner ball~on, that isJ in onder to inject the medicine e55en-~5 ti~l ly in the center area of the constriction beingtreated, the discharge openings 24 are preferably pre-formed in such a manner that theY oPen with incre2sing pressure b2gir,nin~ at the distal end of the head portion to~ard the proximal end. ~ith this arran~ement it is insured that the iniected medicine is not carried away but is applied in sufficiently high concentration to the tissue layers as desired ~nd ~ubsequentlY infiltrates into the deeper wall laye~s. T~e amo~nt of meticine released into the vessel after deflation of the c~theter ~hich normally takes place after about 60 seconds i5 ther, relatively smal~ and it is diluted in a material waY so that a5 far as the dose is concernet it is ~nrelev2nt for the total body system even i~ a large dose was apPlied localized to the treated vessel area. For aPPlication, pr$marily alreadY ~ell known cell-toxic comPounds are used whose effects can be well determined but also Senet-ic~tly designed medicine mzY be used.
Utilization of Pressure generators (indeflator) as n4rmally used in connection with ~alloon dilation per-~its injection and infiltration of medicine into the tis-sue under anY desired pressure 2nt in anY desired prede-termined amount.
tig. S shQws a connectlng strùcture fQr anindeflator ard for an oPerating m~chanism for inJectin~ a medicine. The connectinS structure comPrises a Y connec-tor with a terminal 32 for scavenging ~nd 2 terminal 3-~
1~ far the indeflator. The baltoon catheter 11 i5 connectedto this Y connector. The sleeve catheter 10 which sur-rounds the ~alloQn catheter 11 is provided at its rear end with a connecting struct~re 36 which h~s a terminal 37 through ~hich the ~edicine is supPlied bY means of a p~e5suri2e~ which is not shown in the drawing. Within the connecting structure 3~ the termin~l 37 is connected t~ the outer lumina 18 of the sleeva catheter.
With this connecting structure arrangement the balloon dilation can be Perf~rmed indePendently o~ the application of the medicine so that the medicine can be adminlstered indePendently and in Predetermined am3unts.
Frr the treatment of coronary vessels the invention pr~vides for a substantial advantage in that the elegance of the balloon dilation method is ma;ntained and the procedur~ i5 nat extended because the medicine is injected during the normal dilation procedure during which, furthermore, an exactly defined amount of medicine is administered within a well determined vessel area.
Ho~ever the arrange~ent according to the inven-tion is suitable nat onlY for treatment o~ coronary ves-sels but ~lso for kidney vessel 5 and vessels in sxtremi-ties and, dePendlng on the conditions, also for vessels in the head of a Patient~ It maY al 50 ~e used for the wetting and infiltration of growth-inhibitins comPounds in vessel pont1ons ~f o~gans or tubular systems such as the urethra or the bile duct or other ~essel-like organs.
The arrangement accord1ns ta the invention i5 al50 Par-ticularly well suitet for the treatment of cancerous areas with gr~wth-inhibiting compounds ~in this case cYtostatics). The arrangement ~urther Permits treatment cf tubular structures ridtled with carcinoma without lQ endangering or blocking Passage therethrough that is a1so malicious sicknesses in the area cf the trachea or the intestines can be trea'ed in 2ccord~nce w-th the inven-tion with~ut distunbing passage throu~h the affected ~reaS. Also for the treatment of prostate hypertrophy medicine can ~e ad~inistered in the describet manner.
only to the tissue areas to be treated.
SU~MAR~ OF THF INVFNTION
In a sleeve catheter for 5uppl ying medicine to the walls of a vessel or tubular or~an in which a num~er of outer lumina extend longitudinallY around a c~ntral lumen, the outer lumina have radial discharge o~enings in the area of the head portion of the catheter, which i5 slidable onto a balloon catheter in order ta be dispose~
at least P~rtiallY on the ballo~n of the balloon cathete~
s so as to ~e expandable therebY into abutment with the inner wa1l of a ~essel to be dil~tet wherPby medicine can be supplied through the discha~ge openings in the auter tumina under pressure directty to the tissue cf the ves-sel adjacent the outer lu~ina, thereby ~pplyin~ the medicine solely to the area engaged by the outer surfac~
Gf ~he head portion.
The arrangement according ta the invention h~s the ~d~antag~ that the ~lee~e catheter i5 51 idable onto a ?ortion of the de~lated balloon Or a b~lloon catheter. so ~5 that the low balloon Profile as required for the inser-tion Or the catheter into constricted ~essel area is essentially mainta1ned. Inflation o~ the ballo3n forces the head porticn of the sleeve c~theter into engage~ent with the tissue t~ be treated 50 that, during the dila-tioo procedure the medicine can b~ appl ied, under pres-sure, through the outer l~mina directlY to the tissue to be treated whereby it entens solely this t~sl~e. In this manner all toxic c~mpounds or gene-technologicallY desig-n~ted medicine adaP~ed to inhibit undesirable cell growth 2s in the tr~eated area can be inJected directl y and onl y into the tissue a~ea to be tre.atet.
In a further embodiment accordin~ to the inven-tion the Perforation; are pre~ormed such that they are oPened by application Gf the b~llaon Pressure. They may also be prefarmed in suoh a manner that they are oPened by the applicatiQn of additi~nal pressure to the outer 1umlna.
In order to facil itate the exPansion of the head portion o~ the slee~e catheter, in ~nnther embodi-ment, the head portion is P~o~ided at its outside ~etweenthe dischar~e oPenings with largitudinally extending r~dial notches. ExPansion c~n be fu~ther facilitated by providing longitudinally extenting radial notches al~o in the inner w~ll, bet~een the outer lumina, ~hich i5 dIS-Posed adjacent the inner lumen of the catheter.
In order to administer the medicine as locally as possible. that is, only in the close Pno~imity of the constricted vessel area, or stenosis, it is advan~ageous if the discharge openings are preformed in such a mznner thAt they are oPened sradually with increasing pressure.
beg~nning at the distal end, to~rd the proximal end of IO the head portion. ~epending on the locatiGn where the sleeve catheter i5 to be used in ~onnection wit~ a bal-loon catheter, in vessels or in crgans, it may ~e advan-tageou$ to ~dminister di~ferent am~unts of med~cine for ~etting the tl55ue Qr infiltration into the tissue. It 1~ ls therefore within the scoPe of the presert invention to provide distributed over the circum~erence Or the head portion, 5iX tD twentY outer lumina.
pRIF~ DFSCRLPTI~N ~F THF D~INGS
Th~ advant~ges and features o~ the lnvention are aPParent from the following descriPtion of an embodi-ment d~scribed below with reference to the drawings and def$ne~ in the claims.
Figure 1 shows the head porticn of a 51 eeve catheter disPosed on a ~alloon ~atheter;
Fig. 2 is a cross-sactional view cf the front end o~ the balloon catheter with the h~ad portion of the slee~e catheter disPosed therean Fig. 3 is a c~o~s-sectiona1 view of the inflated ballnon with an exPanded head portion of the 30 51 eeve c~thater, ~ ig. 4 is a cross-sectional view along l ines T~-IV of Fig. 1; and Fig. 5 sho~s the connecting struct~re ~or the operation of the baltoon catheter and the sleeve catheter.
D~$CRIPT~ON OF T~F PRFFRRFD F~ODI~FNT
Figs . 1. ~ and 3 show the detail5 o~ a 51 eeve catheter 1~ dispcsed Gn a bal~oon catheter 11. The sleeve catheter is sliPped onto the bal~oon catheter such that the head Pcrtion 16 extends at least PartiallY oYer the ~allGon 12 which i5 mounted on a flexible guide rod 14 as shown in Fig. 2. In these relative Positions the two catheters are inserted into a vessel or an organ.
~he cuter lumina 18 ter~inate in the head portion cf the 10 51 e~ve catheter and they extend ove~ the full length of the 51 eeve catheter uP to the conneoting structure which is sh~wn in Fig. 5 and explained be~Gw. As shown the outer lumina 18 are arranged in a circle around a central lu~en 20 wherein 6 to 20 4uter lumina maY be pro~ided dePendin~ on the 5ize and the applica~ion area of the sleeve catheter.
It is al S4 p055i~1 e to provide only one or t~o lumina which extend along the sleeve catheter and ~hich ~re divided ~n the head portion inta several outer lumina. The cross-secticn and the arrangement of the lumina are ad~pted to a particular aPp~ication.
In the cross-sectional ~iew of Fig. 4 which is t~ken acr~ss a head porti~n 16 disPoset on a balloon catheter 11. t~ere are ei~ht outer lumin 18 which are - 23 proYided with discharge oPenings 24 leading to the out-side of the head portion. These discharge openings 24 are so designed that theY open only toward the end of balloon pressure aPPlication and then discharge a medicine contained in the outer lumina 1~. It is alsa Possible to preform the discharge ~Penings in 5vch a way that theY open ~nly bY ~PPlication of additional Pressure applied via the connectin~ structure.
In orde~ to facilitate expansion of the head portion 16 it is proY~ded~ at least on the outside, with radial grooves 22 which extent longitudinally between the discharge ~Penings 24 and to a li~ited dePth sPaced from the inner wall of the head Po~tion 50 as to provide for a hin~e structure allowing the radial Sr~oves 22 tc open up and exPand the head portion with on~y sma~l pressure re~uirements. ~n order to ~urther reduce the pressure required for the exPansion of the head portion further radial grooves 23 may ~e provided at the inside of the head portion adjacent the central lumer, 20, the gr~oves 23 extending lon~itudinally between the outer lumin~ 18.
I~ t!~o radial grooves 23 are provided at ~PPosite sides Ot a radial gr~ove ~, three-hinse structures ane form~d which further facilitate exPansion of the head portion.
: With this arran~ement the head portion can be Pressed in sufficiently tight cnntact with the ves~el ~all 5 bY the pressure of, for example, 5 to 8 bar required for full exPansion of the balloon 50 that the medicine, when aPPlied throu~h the oute~ luminc 18 ~nt the disc~arge openin~s 24, will not ~low ~aY but will be applied tn the inner ~all surface in a highly locati~ed fashior, such that it ~ill Penetr~te the wall a~d then infiltrate the inner layers in sufficientlY high concen-trations~
For good distribution ~f the me~icine duringdilation when the head PGrtion is firmlY pressed against the expanded tissue by the pressure built up in ths inner ball~on, that isJ in onder to inject the medicine e55en-~5 ti~l ly in the center area of the constriction beingtreated, the discharge openings 24 are preferably pre-formed in such a manner that theY oPen with incre2sing pressure b2gir,nin~ at the distal end of the head portion to~ard the proximal end. ~ith this arran~ement it is insured that the iniected medicine is not carried away but is applied in sufficiently high concentration to the tissue layers as desired ~nd ~ubsequentlY infiltrates into the deeper wall laye~s. T~e amo~nt of meticine released into the vessel after deflation of the c~theter ~hich normally takes place after about 60 seconds i5 ther, relatively smal~ and it is diluted in a material waY so that a5 far as the dose is concernet it is ~nrelev2nt for the total body system even i~ a large dose was apPlied localized to the treated vessel area. For aPPlication, pr$marily alreadY ~ell known cell-toxic comPounds are used whose effects can be well determined but also Senet-ic~tly designed medicine mzY be used.
Utilization of Pressure generators (indeflator) as n4rmally used in connection with ~alloon dilation per-~its injection and infiltration of medicine into the tis-sue under anY desired pressure 2nt in anY desired prede-termined amount.
tig. S shQws a connectlng strùcture fQr anindeflator ard for an oPerating m~chanism for inJectin~ a medicine. The connectinS structure comPrises a Y connec-tor with a terminal 32 for scavenging ~nd 2 terminal 3-~
1~ far the indeflator. The baltoon catheter 11 i5 connectedto this Y connector. The sleeve catheter 10 which sur-rounds the ~alloQn catheter 11 is provided at its rear end with a connecting struct~re 36 which h~s a terminal 37 through ~hich the ~edicine is supPlied bY means of a p~e5suri2e~ which is not shown in the drawing. Within the connecting structure 3~ the termin~l 37 is connected t~ the outer lumina 18 of the sleeva catheter.
With this connecting structure arrangement the balloon dilation can be Perf~rmed indePendently o~ the application of the medicine so that the medicine can be adminlstered indePendently and in Predetermined am3unts.
Frr the treatment of coronary vessels the invention pr~vides for a substantial advantage in that the elegance of the balloon dilation method is ma;ntained and the procedur~ i5 nat extended because the medicine is injected during the normal dilation procedure during which, furthermore, an exactly defined amount of medicine is administered within a well determined vessel area.
Ho~ever the arrange~ent according to the inven-tion is suitable nat onlY for treatment o~ coronary ves-sels but ~lso for kidney vessel 5 and vessels in sxtremi-ties and, dePendlng on the conditions, also for vessels in the head of a Patient~ It maY al 50 ~e used for the wetting and infiltration of growth-inhibitins comPounds in vessel pont1ons ~f o~gans or tubular systems such as the urethra or the bile duct or other ~essel-like organs.
The arrangement accord1ns ta the invention i5 al50 Par-ticularly well suitet for the treatment of cancerous areas with gr~wth-inhibiting compounds ~in this case cYtostatics). The arrangement ~urther Permits treatment cf tubular structures ridtled with carcinoma without lQ endangering or blocking Passage therethrough that is a1so malicious sicknesses in the area cf the trachea or the intestines can be trea'ed in 2ccord~nce w-th the inven-tion with~ut distunbing passage throu~h the affected ~reaS. Also for the treatment of prostate hypertrophy medicine can ~e ad~inistered in the describet manner.
Claims (5)
1. A sleeve catheter for the wetting and infiltration of a vessel wall or other tubular organ by a fluid, particularly a liquid medicine, said sleeve catheter (10) comprising a head portion (16) with a central lumen (20) and a number of outer lumina (18) extending in cross section in a circle around said central lumen, each having discharge openings (24) formed in the head portion (16) thereof, said sleeve catheter (10) being adapted to be slidable onto a balloon catheter (11), so as to be disposed at least partially on the balloon of said balloon catheter, said head portion (16) including, at its outside, longitudinally extending radial grooves (22) arranged between said discharge openings (24) so as to provide a hinge structure adjacent the inner wall of said sleeve, said discharge openings (24) being perforated such that they open by the application of the balloon pressure, said head portion (16) of said sleeve catheter being expandable for engaging the inner wall of a vessel to be expanded upon inflation of said balloon (12), and said fluid being supplied to said outer lumina (18) under pressure so as to be applied to said vessel wall via said discharge openings (24) when said head portion is in engagement with the inner wall of the vessel wall to be treated.
2. A sleeve catheter according to claim 1, wherein said discharge openings (24) are performed such that they open by the application of the balloon pressure.
3. A sleeve catheter according to claim 1, wherein longitudinally extending radial grooves (23) are provided between said outer lumina (18) also in the inner wall adjacent the central lumen (20) so as to provide a hinge structure adjacent the outer wall of said sleeve,
4. A sleeve catheter according to one or several of the claims 1 to 3, wherein said discharge openings (24) are perforated in such a way that they are opened successively with increasing pressure beginning at the distal end of the head portion (16).
5. A sleeve catheter according to one or several of the claims 1 to 4, wherein said head portion (16) includes six to twenty outer lumina (18) distributed over its circumference.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4324218A DE4324218A1 (en) | 1993-07-19 | 1993-07-19 | Cuff catheter |
DEP4324218.9 | 1993-07-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2167573A1 true CA2167573A1 (en) | 1995-02-02 |
Family
ID=6493202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002167573A Abandoned CA2167573A1 (en) | 1993-07-19 | 1993-10-13 | Sleeve catheter |
Country Status (21)
Country | Link |
---|---|
US (1) | US5364356A (en) |
EP (1) | EP0710132B1 (en) |
JP (1) | JPH09500303A (en) |
KR (1) | KR960703634A (en) |
CN (1) | CN1097633A (en) |
AT (1) | ATE148352T1 (en) |
AU (1) | AU5177593A (en) |
CA (1) | CA2167573A1 (en) |
CZ (1) | CZ284434B6 (en) |
DE (2) | DE4324218A1 (en) |
DK (1) | DK0710132T3 (en) |
ES (1) | ES2096951T3 (en) |
FI (1) | FI960219A (en) |
GR (1) | GR3022431T3 (en) |
HU (1) | HUT73327A (en) |
NO (1) | NO960201L (en) |
PL (1) | PL172711B1 (en) |
SG (1) | SG46505A1 (en) |
SK (1) | SK8696A3 (en) |
TW (1) | TW235246B (en) |
WO (1) | WO1995003081A1 (en) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514091A (en) * | 1988-07-22 | 1996-05-07 | Yoon; Inbae | Expandable multifunctional manipulating instruments for various medical procedures |
US5374261A (en) | 1990-07-24 | 1994-12-20 | Yoon; Inbae | Multifunctional devices for use in endoscopic surgical procedures and methods-therefor |
US6120437A (en) * | 1988-07-22 | 2000-09-19 | Inbae Yoon | Methods for creating spaces at obstructed sites endoscopically and methods therefor |
US5634901A (en) * | 1992-11-02 | 1997-06-03 | Localmed, Inc. | Method of using a catheter sleeve |
US5336178A (en) * | 1992-11-02 | 1994-08-09 | Localmed, Inc. | Intravascular catheter with infusion array |
US5536250A (en) * | 1994-04-01 | 1996-07-16 | Localmed, Inc. | Perfusion shunt device and method |
US5985307A (en) * | 1993-04-14 | 1999-11-16 | Emory University | Device and method for non-occlusive localized drug delivery |
US5599306A (en) * | 1994-04-01 | 1997-02-04 | Localmed, Inc. | Method and apparatus for providing external perfusion lumens on balloon catheters |
US5562620A (en) * | 1994-04-01 | 1996-10-08 | Localmed, Inc. | Perfusion shunt device having non-distensible pouch for receiving angioplasty balloon |
US5810767A (en) * | 1994-05-11 | 1998-09-22 | Localmed, Inc. | Method and apparatus for pressurized intraluminal drug delivery |
US5514093A (en) * | 1994-05-19 | 1996-05-07 | Scimed Life Systems, Inc. | Variable length balloon dilatation catheter |
US5755722A (en) * | 1994-12-22 | 1998-05-26 | Boston Scientific Corporation | Stent placement device with medication dispenser and method |
US5807398A (en) * | 1995-04-28 | 1998-09-15 | Shaknovich; Alexander | Shuttle stent delivery catheter |
US5792116A (en) * | 1995-05-17 | 1998-08-11 | Scimed Life Systems, Inc. | Catheter having geometrically shaped surface and method of manufacture |
US5647846A (en) * | 1995-05-17 | 1997-07-15 | Scimed Life Systems, Inc. | Catheter having geometrically shaped surface and method of manufacture |
US5779673A (en) * | 1995-06-26 | 1998-07-14 | Focal, Inc. | Devices and methods for application of intraluminal photopolymerized gels |
US6102904A (en) * | 1995-07-10 | 2000-08-15 | Interventional Technologies, Inc. | Device for injecting fluid into a wall of a blood vessel |
US5746716A (en) * | 1995-07-10 | 1998-05-05 | Interventional Technologies Inc. | Catheter for injecting fluid medication into an arterial wall |
US5873852A (en) * | 1995-07-10 | 1999-02-23 | Interventional Technologies | Device for injecting fluid into a wall of a blood vessel |
US5713863A (en) * | 1996-01-11 | 1998-02-03 | Interventional Technologies Inc. | Catheter with fluid medication injectors |
US5653689A (en) * | 1995-09-30 | 1997-08-05 | Abacus Design & Development, Inc. | Infusion catheter |
AU2821597A (en) * | 1996-05-03 | 1997-11-26 | Emed Corporation | Combined coronary stent deployment and local delivery of an agent |
FR2758089B1 (en) * | 1997-01-06 | 1999-03-05 | Georges Boussignac | METHOD AND DEVICE FOR EXCHANGING RESPIRATORY TUBE IN THE TRACHEA OF A PATIENT |
US5961536A (en) * | 1997-10-14 | 1999-10-05 | Scimed Life Systems, Inc. | Catheter having a variable length balloon and method of using the same |
US6206283B1 (en) | 1998-12-23 | 2001-03-27 | At&T Corp. | Method and apparatus for transferring money via a telephone call |
US6280411B1 (en) | 1998-05-18 | 2001-08-28 | Scimed Life Systems, Inc. | Localized delivery of drug agents |
US8177743B2 (en) | 1998-05-18 | 2012-05-15 | Boston Scientific Scimed, Inc. | Localized delivery of drug agents |
US6048332A (en) * | 1998-10-09 | 2000-04-11 | Ave Connaught | Dimpled porous infusion balloon |
US6210392B1 (en) | 1999-01-15 | 2001-04-03 | Interventional Technologies, Inc. | Method for treating a wall of a blood vessel |
US6695830B2 (en) * | 1999-01-15 | 2004-02-24 | Scimed Life Systems, Inc. | Method for delivering medication into an arterial wall for prevention of restenosis |
US6955661B1 (en) | 1999-01-25 | 2005-10-18 | Atrium Medical Corporation | Expandable fluoropolymer device for delivery of therapeutic agents and method of making |
US6398758B1 (en) | 1999-02-16 | 2002-06-04 | Stephen C. Jacobsen | Medicament delivery system |
US6302870B1 (en) | 1999-04-29 | 2001-10-16 | Precision Vascular Systems, Inc. | Apparatus for injecting fluids into the walls of blood vessels, body cavities, and the like |
US6478778B1 (en) | 1999-05-28 | 2002-11-12 | Precision Vascular Systems, Inc. | Apparatus for delivering fluids to blood vessels, body cavities, and the like |
US6464662B1 (en) | 2000-07-26 | 2002-10-15 | Image-Guided Neurologics, Inc. | Drug delivery and catheter systems, apparatus and processes |
EP1311310A4 (en) * | 2000-08-21 | 2004-11-24 | Cleveland Clinic Foundation | Microneedle array module and method of fabricating the same |
US7803149B2 (en) | 2002-07-12 | 2010-09-28 | Cook Incorporated | Coated medical device |
US8071740B2 (en) * | 2000-11-17 | 2011-12-06 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
EP1258230A3 (en) | 2001-03-29 | 2003-12-10 | CardioSafe Ltd | Balloon catheter device |
CN100506284C (en) | 2001-10-19 | 2009-07-01 | 脉管生物生长有限公司 | Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
WO2003082076A2 (en) | 2002-03-25 | 2003-10-09 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure clips |
WO2003103476A2 (en) | 2002-06-05 | 2003-12-18 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure device with radial and circumferential support |
WO2004037333A1 (en) * | 2002-10-25 | 2004-05-06 | Nmt Medical, Inc. | Expandable sheath tubing |
WO2004052213A1 (en) | 2002-12-09 | 2004-06-24 | Nmt Medical, Inc. | Septal closure devices |
US7678123B2 (en) | 2003-07-14 | 2010-03-16 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
DE602004017750D1 (en) | 2003-08-19 | 2008-12-24 | Nmt Medical Inc | Expandable lock hose |
US20050273119A1 (en) | 2003-12-09 | 2005-12-08 | Nmt Medical, Inc. | Double spiral patent foramen ovale closure clamp |
US8308760B2 (en) | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
US7842053B2 (en) | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
US20050273075A1 (en) * | 2004-06-08 | 2005-12-08 | Peter Krulevitch | Method for delivering drugs to the adventitia using device having microprojections |
US20050273049A1 (en) * | 2004-06-08 | 2005-12-08 | Peter Krulevitch | Drug delivery device using microprojections |
JP2005349202A (en) * | 2004-06-08 | 2005-12-22 | Cordis Corp | Instrument and method for delivering therapeutic agent into tissue |
EP1773439A4 (en) * | 2004-07-14 | 2010-01-20 | By Pass Inc | Material delivery system |
WO2006036837A2 (en) | 2004-09-24 | 2006-04-06 | Nmt Medical, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
US8771257B2 (en) * | 2004-10-15 | 2014-07-08 | Boston Scientific Scimed, Inc. | Drug delivery sheath |
WO2006055826A2 (en) | 2004-11-18 | 2006-05-26 | Chang David W | Endoluminal delivery of anesthesia |
US20060161135A1 (en) * | 2005-01-18 | 2006-07-20 | Vanderwoude Brian J | Ribbed catheter |
WO2006114783A2 (en) * | 2005-04-28 | 2006-11-02 | Bypass, Inc. | Material delivery system |
US7938851B2 (en) | 2005-06-08 | 2011-05-10 | Xtent, Inc. | Devices and methods for operating and controlling interventional apparatus |
US8157851B2 (en) | 2005-06-08 | 2012-04-17 | Xtent, Inc. | Apparatus and methods for deployment of multiple custom-length prostheses |
WO2007002304A2 (en) | 2005-06-22 | 2007-01-04 | Vnus Medical Technologies, Inc. | Methods and apparatus for introducing tumescent fluid to body tissue |
US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
WO2008131167A1 (en) | 2007-04-18 | 2008-10-30 | Nmt Medical, Inc. | Flexible catheter system |
US20080300571A1 (en) * | 2007-05-30 | 2008-12-04 | Lepivert Patrick | Process and device for selectively treating interstitial tissue |
WO2008152639A2 (en) * | 2007-06-12 | 2008-12-18 | Bypass, Inc. | Pressure pulse actuating device for delivery systems |
US9370642B2 (en) | 2007-06-29 | 2016-06-21 | J.W. Medical Systems Ltd. | Adjustable-length drug delivery balloon |
EP2375829B1 (en) | 2007-08-20 | 2013-12-11 | BlackBerry Limited | Discontinuous reception with extended awake period |
WO2009111716A1 (en) * | 2008-03-06 | 2009-09-11 | Boston Scientific Scimed, Inc. | Balloon catheter devices with sheath covering |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
US9636094B2 (en) | 2009-06-22 | 2017-05-02 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
WO2011028419A1 (en) * | 2009-08-27 | 2011-03-10 | Boston Scientific Scimed, Inc. | Balloon catheter devices with drug-coated sheath |
US20110301565A1 (en) * | 2010-06-07 | 2011-12-08 | Boston Scientific Scimed, Inc. | Medical balloons having a sheath designed to facilitate release of therapeutic agent |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
WO2013106347A1 (en) | 2012-01-10 | 2013-07-18 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and devices for the prevention of surgical site infections |
WO2013136321A1 (en) * | 2012-03-15 | 2013-09-19 | Flip Technologies Limited | A balloon catheter and a system and a method for determining the distance of a site in a human or animal body from a datum location |
US10327751B2 (en) | 2013-03-20 | 2019-06-25 | Prescient Surgical, Inc. | Methods and apparatus for reducing the risk of surgical site infections |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
EP2967531A4 (en) | 2013-03-14 | 2016-08-24 | Prescient Surgical Inc | Methods and devices for the prevention of incisional surgical site infections |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
EP3419676B1 (en) * | 2016-02-22 | 2022-08-31 | Board of Regents, The University of Texas System | Antimicrobial compositions and uses thereof |
CN109310284B (en) * | 2016-04-19 | 2021-09-14 | 波士顿科学国际有限公司 | Liquid seepage balloon device |
WO2019094502A1 (en) | 2017-11-07 | 2019-05-16 | Prescient Surgical, Inc. | Methods and apparatus for prevention of surgical site infection |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3593713A (en) * | 1968-07-12 | 1971-07-20 | Stanley A Bogoff | Catheter combination |
US3981299A (en) * | 1971-03-15 | 1976-09-21 | Harry Elmer Murray | Urethral catheter |
US4423725A (en) * | 1982-03-31 | 1984-01-03 | Baran Ostap E | Multiple surgical cuff |
US4693243A (en) * | 1983-01-14 | 1987-09-15 | Buras Sharon Y | Conduit system for directly administering topical anaesthesia to blocked laryngeal-tracheal areas |
SE442377B (en) * | 1984-06-29 | 1985-12-23 | Mediplast Ab | CATS, HEALTH OR SIMILAR DEVICE |
SU1362481A1 (en) * | 1985-08-12 | 1987-12-30 | А.И.Власов | Arrangement for introducing medicinal means to cavity |
US4753640A (en) * | 1986-10-06 | 1988-06-28 | Catheter Technology Corporation | Catheters and methods |
DE3821544C2 (en) * | 1988-06-25 | 1994-04-28 | H Prof Dr Med Just | Dilatation catheter |
US5021044A (en) * | 1989-01-30 | 1991-06-04 | Advanced Cardiovascular Systems, Inc. | Catheter for even distribution of therapeutic fluids |
US5146916A (en) * | 1990-01-05 | 1992-09-15 | Catalani Angelo S | Endotracheal tube incorporating a drug-irrigation device |
US5049132A (en) * | 1990-01-08 | 1991-09-17 | Cordis Corporation | Balloon catheter for delivering therapeutic agents |
US5180366A (en) * | 1990-10-10 | 1993-01-19 | Woods W T | Apparatus and method for angioplasty and for preventing re-stenosis |
US5102402A (en) * | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
US5178611A (en) * | 1991-05-01 | 1993-01-12 | Paul Rosenberg | Device and method for inhibiting intravascular device associated infection |
US5257974A (en) * | 1992-08-19 | 1993-11-02 | Scimed Life Systems, Inc. | Performance enhancement adaptor for intravascular balloon catheter |
US5279565A (en) * | 1993-02-03 | 1994-01-18 | Localmed, Inc. | Intravascular treatment apparatus and method |
-
1993
- 1993-07-19 DE DE4324218A patent/DE4324218A1/en not_active Withdrawn
- 1993-10-07 US US08/132,877 patent/US5364356A/en not_active Expired - Fee Related
- 1993-10-13 JP JP7504868A patent/JPH09500303A/en active Pending
- 1993-10-13 WO PCT/EP1993/002830 patent/WO1995003081A1/en active IP Right Grant
- 1993-10-13 SG SG1996005328A patent/SG46505A1/en unknown
- 1993-10-13 CZ CZ96116A patent/CZ284434B6/en unknown
- 1993-10-13 HU HU9600104A patent/HUT73327A/en unknown
- 1993-10-13 DE DE59305366T patent/DE59305366D1/en not_active Expired - Fee Related
- 1993-10-13 ES ES93922950T patent/ES2096951T3/en not_active Expired - Lifetime
- 1993-10-13 AT AT93922950T patent/ATE148352T1/en not_active IP Right Cessation
- 1993-10-13 SK SK86-96A patent/SK8696A3/en unknown
- 1993-10-13 PL PL93312612A patent/PL172711B1/en unknown
- 1993-10-13 AU AU51775/93A patent/AU5177593A/en not_active Abandoned
- 1993-10-13 DK DK93922950.6T patent/DK0710132T3/en active
- 1993-10-13 KR KR1019960700100A patent/KR960703634A/en active IP Right Grant
- 1993-10-13 EP EP93922950A patent/EP0710132B1/en not_active Expired - Lifetime
- 1993-10-13 CA CA002167573A patent/CA2167573A1/en not_active Abandoned
- 1993-10-16 TW TW082108602A patent/TW235246B/en active
-
1994
- 1994-03-02 CN CN94102024A patent/CN1097633A/en active Pending
-
1996
- 1996-01-17 FI FI960219A patent/FI960219A/en not_active Application Discontinuation
- 1996-01-17 NO NO960201A patent/NO960201L/en unknown
-
1997
- 1997-01-30 GR GR970400073T patent/GR3022431T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
CZ11696A3 (en) | 1996-04-17 |
EP0710132B1 (en) | 1997-01-29 |
TW235246B (en) | 1994-12-01 |
GR3022431T3 (en) | 1997-04-30 |
ATE148352T1 (en) | 1997-02-15 |
EP0710132A1 (en) | 1996-05-08 |
DK0710132T3 (en) | 1997-06-02 |
NO960201D0 (en) | 1996-01-17 |
CZ284434B6 (en) | 1998-11-11 |
DE4324218A1 (en) | 1995-01-26 |
ES2096951T3 (en) | 1997-03-16 |
NO960201L (en) | 1996-01-17 |
HUT73327A (en) | 1996-07-29 |
FI960219A0 (en) | 1996-01-17 |
AU5177593A (en) | 1995-02-20 |
JPH09500303A (en) | 1997-01-14 |
WO1995003081A1 (en) | 1995-02-02 |
SG46505A1 (en) | 1998-02-20 |
HU9600104D0 (en) | 1996-03-28 |
PL172711B1 (en) | 1997-11-28 |
US5364356A (en) | 1994-11-15 |
DE59305366D1 (en) | 1997-03-13 |
FI960219A (en) | 1996-01-17 |
PL312612A1 (en) | 1996-04-29 |
SK8696A3 (en) | 1996-05-08 |
CN1097633A (en) | 1995-01-25 |
KR960703634A (en) | 1996-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2167573A1 (en) | Sleeve catheter | |
US9782562B2 (en) | Venous insufficiency treatment method | |
CN104884118B (en) | Vascular surrounding tissue ablation catheter with supporting construction | |
DE4233816C2 (en) | Therapeutic device using heat | |
US5693029A (en) | Pro-cell intra-cavity therapeutic agent delivery device | |
KR930002271B1 (en) | Intravascular drug delivery dilatation catheter | |
US5464395A (en) | Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway | |
US20020165520A1 (en) | Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia | |
US20070270757A1 (en) | Needle array devices and methods | |
US20080114286A1 (en) | Infusion Catheter | |
CN107899126A (en) | For vascular wall injection and the conduit system of blood vessel week kidney denervation | |
EP3294171B1 (en) | System for treating the bladder with condensable vapor | |
CA2633666A1 (en) | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach | |
WO2010090953A2 (en) | Dual-lumen catheter for medical device delivery systems | |
CN107106237B (en) | Medical device for treating defective blood, body and body vessels | |
US20030100934A1 (en) | Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts | |
US20150297870A1 (en) | Catheter for administering active agents | |
US20210085932A1 (en) | Controlled pressure reperfusion catheter | |
US20200061351A1 (en) | Balloon within balloon catheter system and methods of use | |
EP3843633A1 (en) | Balloon within balloon catheter system and methods of use | |
JP2004035414A (en) | Inhibitor of penetration into vascular wall of vascular stem cell | |
Thompson | Principles of surgical oncology | |
EP0871511A4 (en) | Angioplasty method and means for performing angioplasty |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |